Skip to content
Search

Latest Stories

RPS has concerns around implementation and delivery of proposed service specifications for PCNs

The Royal Pharmaceutical Society (RPS) has expressed concerns over the implementation and delivery of the proposed service specifications for Primary Care Networks (PCNs).

In its response to the NHS consultation on PCNs, the Society welcomed the proposal for additional medical and pharmacy workforce as part of the PCN agreement as it "would help to deliver the current workload and improve patient access."


"Whilst we support the intention of these draft service specifications, we have concerns around implementation and delivery which we hope will be addressed during this consultation process. These include making best use of pharmacists’ skills and knowledge, the pace of implementation and impact on workload, workforce and recruitment," RPS said in a statement.

The consultation, which closed on Wednesday, mentions five draft service specifications that PCNs will be required to deliver from April, this year.

According to the consultation document, an average PCN could engage around three whole-time equivalent (WTE) clinical pharmacists, 1.5 WTE social prescribing link workers, 0.5 WTE physiotherapists and 0.5 WTE physician associates from April 2020.

“This would provide more than sufficient capacity to deliver the requirements across all five services with significant capacity remaining for these additional roles to provide wider support to GP workforce pressures by handling appointments or queries that would otherwise have been the responsibly of the GP,” the document read.

RPS reiterated that it had long advocated for the increasing use of pharmacists’ skills and expertise across the NHS.

Last week, the Royal College of General Practitioners (RCGP) suggested NHS England should take more time to properly consult the profession and proposed to create new service specification that is less perspective, more locally relevant and realistic.

Professor Martin Marshall, Chair of RCGP, said: "Primary Care Networks are an opportunity to do things differently and increase support to practices by facilitating collaboration and increased funding getting to the frontline, but serious consideration needs to be given to how PCNs are developed and how the services they can offer are implemented."

"This needs to be well-informed by those working in general practice, and the consultation period we have been given to feedback on the proposed specifications is far too short to be meaningful,” Marshall added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less